Table: begin end state 1 26 cytoplasmic 27 47 transmembrane 48 53 non-cytoplasmic 54 73 transmembrane 74 106 cytoplasmic 107 129 transmembrane 130 134 non-cytoplasmic 135 153 transmembrane 154 163 cytoplasmic 164 187 transmembrane 188 207 non-cytoplasmic 208 230 transmembrane 231 249 cytoplasmic 250 270 transmembrane 271 290 non-cytoplasmic 291 313 transmembrane 314 343 cytoplasmic 344 361 transmembrane 362 366 non-cytoplasmic 367 388 transmembrane 389 408 cytoplasmic 409 431 transmembrane 432 436 non-cytoplasmic 437 456 transmembrane 457 472 cytoplasmic
Input: >AO353_16120 AO353_16120 D-alanine/D-serine/glycine permease MTVGNHLPHGETAQGGPLKRELGERHIRLMALGACIGVGLFLGSAKAIEMAGPAIMLSYI IGGLAILVIMRALGEMAVHNPVAGSFSRYAQDYLGPLAGFLTGWNYWFLWLVTCVAEITA VAVYMGIWFPEVPRWIWALAALVSMGSINLIAVKAFGEFEFWFALIKIVTIIAMVVGGVG VIAFGFGNDGVALGISNLWSHGGFMPNGVQGVLMSLQMVMFAYLGVEMIGLTAGEAKNPQ KTIPNAIGSVFWRILLFYVGALFVILSIYPWNEIGTQGSPFVMTFERLGIKTAAGIINFV VITAALSSCNGGIFSTGRMLYSLAQNGQAPAGFAKTSNGVPRRALLLSIGALLLGVLLNY LVPEKVFVWVTAIATFGAIWTWVMILLAQLKFRKGLSPAERAALKYRMWLYPVSSYLALA FLVMVVGLMAYFPDTRVALYVGPAFLVLLTVLFYVFKLQPTGVPQAAVRTAS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server